Drug treatments show mixed results for borderline personality disorder

A new study examining real-world outcomes of pharmacological treatments for borderline personality disorder reveals significant gaps between clinical expectations and actual patient results. The finding matters to healthcare systems and insurers wrestling with treatment decisions and cost-effectiveness for one of psychiatry's most complex conditions.

Originaltitel: Association of pharmacological treatments and real-world outcomes in borderline personality disorder